Akari Therapeutics (AKTX) Return on Equity Growth (1y) (2016 - 2026)
Akari Therapeutics (AKTX) Return on Equity Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | 105.00 |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -3.00 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 0.00 |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -1.00 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 0.00 |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 10.00 |
| 10 | Regeneron Pharmaceuticals | 63.59 Bn | 54.83 Bn | 3.31 Bn | 0.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.00 |
| Dec 31, 2025 | 2.00 |
| Sep 30, 2025 | -5.00 |
| Jun 30, 2025 | -6.00 |
| Mar 31, 2025 | -10.00 |
| Dec 31, 2024 | -2,093.00 |
| Sep 30, 2024 | 12.00 |
| Jun 30, 2024 | 8.00 |
| Mar 31, 2024 | 12.00 |
| Dec 31, 2023 | 2,092.00 |
| Dec 31, 2022 | 0.00 |
| Dec 31, 2021 | 0.00 |
| Dec 31, 2020 | 5.00 |
| Sep 30, 2020 | 0.00 |
| Jun 30, 2020 | -2.00 |
| Mar 31, 2020 | -13.00 |
| Dec 31, 2019 | -7.00 |
| Dec 31, 2018 | 0.00 |
| Dec 31, 2017 | 1.00 |
| Dec 31, 2016 | 0.00 |